找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Muscle Invasive Bladder Cancer; Sanchia S. Goonewardene,Karen Ventii,David Albala Book 2021 The Editor(s) (if applicable) an

[復(fù)制鏈接]
樓主: IU421
11#
發(fā)表于 2025-3-23 13:45:26 | 只看該作者
12#
發(fā)表于 2025-3-23 15:34:28 | 只看該作者
Management of Urologyhttp://image.papertrans.cn/m/image/622552.jpg
13#
發(fā)表于 2025-3-23 19:51:08 | 只看該作者
14#
發(fā)表于 2025-3-24 01:21:38 | 只看該作者
15#
發(fā)表于 2025-3-24 04:29:35 | 只看該作者
Epidemiology, Risk Factors and Occupational Hazardscer epidemiology, risk factors and occupational hazards. The search strategy aimed to identify all references related to bladder cancer AND screening. Search terms used were as follows: (Bladder cancer) AND (Epidemiology) AND (Risk Factors) AND (Occupational Hazards). The following databases were sc
16#
發(fā)表于 2025-3-24 10:10:08 | 只看該作者
The Molecular Basis of Muscle Invasive Bladder Cancer The search strategy aimed to identify all references related to bladder cancer AND muscle invasive disease AND molecular basis. Search terms used were as follows: (Bladder cancer) AND (muscle invasive disease) AND (Molecular Basis). The following databases were screened from 1989 to June 2020. The
17#
發(fā)表于 2025-3-24 13:16:18 | 只看該作者
18#
發(fā)表于 2025-3-24 18:34:19 | 只看該作者
Histological Variants in Muscle Invasive Bladder Cancer: Sarcomatoid Cancerified in the 2004 World Health Organization Classification (Amin, Mod Pathol 22(Suppl 2):S96–S118, 2009). These histological variants have a significant diagnostic and therapeutic impact. This chapter covers causes of Sarcomatoid bladder cancer, diagnostics in sarcomatoid bladder cancer, survival ou
19#
發(fā)表于 2025-3-24 22:42:45 | 只看該作者
20#
發(fā)表于 2025-3-25 01:02:47 | 只看該作者
Bladder Cancer Screeningary Profiles in Bladder Cancer Screening, Mitochondrial DNA in Bladder Cancer Screening, Tyr-phosphorylated proteins in Bladder Cancer Screening, GC-Globulin in Bladder Cancer Screening, Methylation Status with p16 and p14 in Bladder Cancer Screening, Urine Tumour associated Trypsin Inhibitor, mRNA
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 10:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
肥西县| 内江市| 黔江区| 华宁县| 玉山县| 彰化市| 大田县| 塘沽区| 广元市| 壶关县| 获嘉县| 文化| 灌南县| 明溪县| 台安县| 莱州市| 郑州市| 宝山区| 鄂伦春自治旗| 阳山县| 舞阳县| 金门县| 大埔区| 日喀则市| 许昌县| 贺兰县| 大埔县| 宝丰县| 天长市| 金昌市| 沂水县| 吴堡县| 色达县| 漳平市| 河南省| 三都| 周口市| 达州市| 吉木乃县| 涡阳县| 武汉市|